Prediction Trough Concentrations of Valproic Acid Among Chinese Adult Patients with Epilepsy Using Machine Learning Techniques
- PMID: 39843764
- DOI: 10.1007/s11095-025-03817-3
Prediction Trough Concentrations of Valproic Acid Among Chinese Adult Patients with Epilepsy Using Machine Learning Techniques
Abstract
Objective: This study aimed to establish an optimal model based on machine learning (ML) to predict Valproic acid (VPA) trough concentrations in Chinese adult epilepsy patients.
Methods: A single-center retrospective study was carried out at the Jinshan Hospital affiliated with Fudan University from January 2022 to December 2023. A total of 102 VPA trough concentrations were split into a derivation cohort and a validation cohort at a ratio of 8:2. Thirteen ML algorithms were developed using 27 variables in the derivation cohort and were filtered by the lowest mean absolute error (MAE) value. In addition, feature selection was applied to optimize the model.
Results: Ultimately, the extra tree algorithm was chosen to establish the personalized VPA trough concentration prediction model due to its best performance (MAE = 13.08). The SHapley Additive exPlanations (SHAP) plots were used to visualize and rank the importance of features, providing insights into how each feature influences the model's predictions. After feature selection, we found that the model with the top 9 variables [including daily dose, last dose, uric acid (UA), platelet (PLT), combination, gender, weight, albumin (ALB), aspartate aminotransferase (AST)] outperformed the model with 27 variables, with MAE of 6.82, RMSE of 9.62, R2 value of 0.720, relative accuracy (±20%) of 61.90%, and absolute accuracy (±20 mg/L) of 90.48%.
Conclusion: In conclusion, the trough concentration prediction model for VPA in Chinese adult epileptic patients based on the extra tree algorithm demonstrated strong predictive ability which is valuable for clinicians in medication guidance.
Keywords: chinese adult epileptic patients; machine learning; prediction; trough concentration; valproic acid.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Ethics Statement: The study involving humans was approved by the Hospital Ethics Committee of the Jinshan Hospital affiliated with Fudan University (Approval No. JIEC 2024-S67). The study was performed in accordance with the Declaration of Helsinki. Written informed consent from patients was waived by the Hospital Ethics Committee. Conflict of Interest: The authors declare no competing interests in this work.
Similar articles
-
Joint use of population pharmacokinetics and machine learning for prediction of valproic acid plasma concentration in elderly epileptic patients.Eur J Pharm Sci. 2024 Oct 1;201:106876. doi: 10.1016/j.ejps.2024.106876. Epub 2024 Aug 10. Eur J Pharm Sci. 2024. PMID: 39128815
-
Correlation between plasma ammonia level and serum trough concentration of free valproic acid in patients with epilepsy.Biol Pharm Bull. 2012;35(6):971-4. doi: 10.1248/bpb.35.971. Biol Pharm Bull. 2012. PMID: 22687541
-
Population pharmacokinetics of valproic acid in adult Chinese epileptic patients and its application in an individualized dosage regimen.Ther Drug Monit. 2015 Feb;37(1):76-83. doi: 10.1097/FTD.0000000000000100. Ther Drug Monit. 2015. PMID: 24831653
-
Influence of CYP2C9 and CYP2A6 on plasma concentrations of valproic acid: a meta-analysis.Eur J Clin Pharmacol. 2020 Aug;76(8):1053-1058. doi: 10.1007/s00228-020-02872-6. Epub 2020 May 8. Eur J Clin Pharmacol. 2020. PMID: 32385545
-
Effect of UGT2B7 genotypes on plasma concentration of valproic acid: a meta-analysis.Eur J Clin Pharmacol. 2018 Apr;74(4):433-442. doi: 10.1007/s00228-017-2395-z. Epub 2017 Dec 14. Eur J Clin Pharmacol. 2018. PMID: 29243113 Review.
References
-
- Chen S, Wu H, Klebe D, et al. Valproic acid: a new candidate of therapeutic application for the acute central nervous system injuries. Neurochem Res. 2014;39(9):1621–33. - PubMed
-
- Pascali JP, Giorgetti A, Barone R, et al. Valproic acid determination by liquid chromatography coupled to mass spectrometry (LC-MS/MS) in whole blood for forensic purposes. Drug Test Anal. 2023;15(1):128–33. - PubMed
-
- Mei S, Feng W, Zhu L, et al. Effect of CYP2C19, UGT1A8, and UGT2B7 on valproic acid clearance in children with epilepsy: a population pharmacokinetic model. Eur J Clin Pharmacol. 2018;74(8):1029–36. - PubMed
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous